HQL logo

Tekla Life Sciences Investors (HQL) EBITDA

Quarterly EBITDA

N/A

30 September 2023

HQL Quarterly EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBITDA

N/A

30 September 2023

HQL TTM EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HQL EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

HQL EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time

Tekla Life Sciences Investors EBITDA History

DateAnnualQuarterlyTTM
Mar 2020
-
$60.85 M(-199.0%)
-$586.09 K(-99.0%)
Sept 2019
-
-$61.43 M(<-9900.0%)
-$61.43 M(-162.3%)
DateAnnualQuarterlyTTM
Mar 2019
-
$0.00(-100.0%)
$98.64 M(0.0%)
Sept 2018
-
$98.64 M
$98.64 M

FAQ

  • What is the all time high quarterly EBITDA for Tekla Life Sciences Investors?
  • What is the all time high TTM EBITDA for Tekla Life Sciences Investors?

What is the all time high quarterly EBITDA for Tekla Life Sciences Investors?

Tekla Life Sciences Investors all-time high quarterly earnings before interest, taxes, depreciation & amortization is $98.64 M

What is the all time high TTM EBITDA for Tekla Life Sciences Investors?

Tekla Life Sciences Investors all-time high TTM earnings before interest, taxes, depreciation & amortization is $98.64 M